The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE

Xehetasun bibliografikoak
Egile Nagusiak: Damphousse, C, Groves, C, Brown, T, Lowe, L, Nickerson-Nutter, C, Collins, M, Jr, O, Young, D
Formatua: Conference item
Argitaratua: 2006
_version_ 1826277938144739328
author Damphousse, C
Groves, C
Brown, T
Lowe, L
Nickerson-Nutter, C
Collins, M
Jr, O
Young, D
author_facet Damphousse, C
Groves, C
Brown, T
Lowe, L
Nickerson-Nutter, C
Collins, M
Jr, O
Young, D
author_sort Damphousse, C
collection OXFORD
description
first_indexed 2024-03-06T23:36:26Z
format Conference item
id oxford-uuid:6dd40b8c-c9a6-4caa-8fee-9627f1f87bb8
institution University of Oxford
last_indexed 2024-03-06T23:36:26Z
publishDate 2006
record_format dspace
spelling oxford-uuid:6dd40b8c-c9a6-4caa-8fee-9627f1f87bb82022-03-26T19:20:17ZThe interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLEConference itemhttp://purl.org/coar/resource_type/c_5794uuid:6dd40b8c-c9a6-4caa-8fee-9627f1f87bb8Symplectic Elements at Oxford2006Damphousse, CGroves, CBrown, TLowe, LNickerson-Nutter, CCollins, MJr, OYoung, D
spellingShingle Damphousse, C
Groves, C
Brown, T
Lowe, L
Nickerson-Nutter, C
Collins, M
Jr, O
Young, D
The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE
title The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE
title_full The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE
title_fullStr The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE
title_full_unstemmed The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE
title_short The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE
title_sort interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic gvh model of sle
work_keys_str_mv AT damphoussec theinterleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT grovesc theinterleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT brownt theinterleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT lowel theinterleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT nickersonnutterc theinterleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT collinsm theinterleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT jro theinterleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT youngd theinterleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT damphoussec interleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT grovesc interleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT brownt interleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT lowel interleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT nickersonnutterc interleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT collinsm interleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT jro interleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle
AT youngd interleukin21pathwayiscriticalfordevelopmentofpathogenicantibodiesinachronicgvhmodelofsle